🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/12/2020 | 79,98 | 80,04 | 78,76 | 79,65 | +0,35% | 1,60% | 7.168.320 |
| 08/12/2020 | 78,52 | 79,90 | 78,49 | 79,37 | +0,81% | 1,80% | 8.664.969 |
| 07/12/2020 | 78,30 | 79,65 | 78,29 | 78,73 | +0,70% | 1,73% | 8.829.190 |
| 04/12/2020 | 77,42 | 78,21 | 77,40 | 78,19 | +0,60% | 1,05% | 8.651.554 |
| 03/12/2020 | 78,19 | 78,22 | 77,12 | 77,72 | -0,46% | 1,40% | 7.085.109 |
| 02/12/2020 | 78,19 | 78,95 | 77,57 | 78,08 | +0,34% | 1,77% | 7.165.805 |
| 01/12/2020 | 77,24 | 78,68 | 77,12 | 77,81 | +1,44% | 2,03% | 10.166.543 |
| 30/11/2020 | 76,34 | 76,85 | 75,77 | 76,71 | +0,66% | 1,41% | 14.501.910 |
| 27/11/2020 | 76,62 | 76,98 | 75,92 | 76,20 | -0,25% | 1,39% | 5.644.528 |
| 25/11/2020 | 76,47 | 76,77 | 75,95 | 76,39 | -0,10% | 1,07% | 6.023.590 |
| 24/11/2020 | 76,36 | 77,19 | 76,02 | 76,47 | -0,17% | 1,52% | 12.790.840 |
| 23/11/2020 | 76,92 | 77,44 | 75,74 | 76,60 | -0,21% | 2,21% | 9.498.548 |
| 20/11/2020 | 76,78 | 77,11 | 76,08 | 76,77 | +0,07% | 1,34% | 8.415.440 |
| 19/11/2020 | 77,07 | 77,07 | 75,70 | 76,71 | +0,17% | 1,78% | 7.037.110 |
| 18/11/2020 | 77,70 | 78,22 | 76,56 | 76,57 | -1,53% | 2,14% | 8.678.174 |
| 17/11/2020 | 77,35 | 78,21 | 76,73 | 77,77 | +1,65% | 1,91% | 9.509.133 |
| 16/11/2020 | 77,51 | 78,14 | 76,05 | 76,51 | -1,12% | 2,70% | 9.503.474 |
| 13/11/2020 | 76,56 | 78,10 | 76,07 | 77,38 | +1,54% | 2,65% | 7.694.206 |
| 12/11/2020 | 76,86 | 77,29 | 75,41 | 76,20 | -1,48% | 2,45% | 7.464.799 |
| 11/11/2020 | 78,12 | 78,12 | 76,90 | 77,35 | -0,06% | 1,56% | 5.741.678 |
| 10/11/2020 | 78,03 | 78,27 | 77,30 | 77,40 | +0,76% | 1,25% | 8.593.914 |
| 09/11/2020 | 80,90 | 81,27 | 76,67 | 76,81 | +0,17% | 5,69% | 11.184.046 |
| 06/11/2020 | 75,81 | 77,42 | 75,81 | 76,68 | -0,12% | 2,13% | 6.945.515 |
| 05/11/2020 | 78,30 | 79,10 | 76,76 | 76,77 | -0,20% | 3,00% | 9.277.210 |
| 04/11/2020 | 76,28 | 79,09 | 75,90 | 76,93 | +4,81% | 4,19% | 14.731.422 |
| 03/11/2020 | 73,92 | 74,65 | 73,24 | 73,40 | +0,27% | 1,90% | 7.693.578 |
| 02/11/2020 | 72,95 | 73,34 | 72,18 | 73,20 | +1,99% | 1,60% | 8.145.475 |
| 30/10/2020 | 71,93 | 72,41 | 70,55 | 71,77 | -0,90% | 2,59% | 11.096.748 |
| 29/10/2020 | 72,68 | 73,08 | 71,25 | 72,41 | -0,38% | 2,52% | 9.314.310 |
| 28/10/2020 | 73,60 | 74,17 | 72,54 | 72,69 | -2,32% | 2,22% | 8.989.954 |